文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

香料毒品不仅仅是无害的草药混合物:合成大麻素的药理学和毒理学综述。

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

机构信息

Arkansas Department of Health, Public Health Laboratory, Little Rock, AR, United States.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):234-43. doi: 10.1016/j.pnpbp.2012.04.017. Epub 2012 Apr 26.


DOI:10.1016/j.pnpbp.2012.04.017
PMID:22561602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3936256/
Abstract

"K2" and "Spice" drugs (collectively hereafter referred to as Spice) represent a relatively new class of designer drugs that have recently emerged as popular alternatives to marijuana, otherwise characterized as "legal highs". These drugs are readily available on the Internet and sold in many head shops and convenience stores under the disguise of innocuous products like herbal blends, incense, or air fresheners. Although package labels indicate "not for human consumption", the number of intoxicated people presenting to emergency departments is dramatically increasing. The lack of validated and standardized human testing procedures and an endless supply of potential drugs of abuse are primary reasons why researchers find it difficult to fully characterize clinical consequences associated with Spice. While the exact chemical composition and toxicology of Spice remains to be determined, there is mounting evidence identifying several synthetic cannabinoids as causative agents responsible for psychoactive and adverse physical effects. This review provides updates of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances. The pharmacological and toxicological consequences of synthetic cannabinoid abuse are also reviewed to provide a future perspective on potential short- and long-term implications.

摘要

“K2”和“香料”(统称香料)代表了一类相对较新的设计师药物,最近作为大麻的流行替代品出现,通常被称为“合法兴奋剂”。这些药物在互联网上很容易买到,并在许多专卖店和便利店以草药混合物、香薰或空气清新剂等无害产品的形式出售。尽管包装标签上注明“不可食用”,但因摄入这些药物而到急诊室就诊的人数却在急剧增加。缺乏经过验证和标准化的人体测试程序以及源源不断的潜在滥用药物,是研究人员难以充分描述与香料相关的临床后果的主要原因。虽然香料的确切化学成分和毒理学仍有待确定,但越来越多的证据表明,几种合成大麻素是导致精神活性和不良身体影响的原因。本文综述了在 Spice 中检测到的常见合成大麻素的法律地位的最新情况,以及用于检测 Spice 产品和在各种临床情况下收集的人体标本的分析程序。还综述了合成大麻素滥用的药理学和毒理学后果,以期对潜在的短期和长期影响提供未来展望。

相似文献

[1]
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Prog Neuropsychopharmacol Biol Psychiatry. 2012-4-26

[2]
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Life Sci. 2013-9-29

[3]
[Spice drugs: cannabinoids as a new designer drugs].

Adicciones. 2009

[4]
Spicing things up: synthetic cannabinoids.

Psychopharmacology (Berl). 2013-7-9

[5]
Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Front Behav Neurosci. 2011-9-21

[6]
Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.

J Mass Spectrom. 2013-6

[7]
"Legal highs" - new players in the old drama.

Curr Drug Abuse Rev. 2011-6

[8]
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.

Int J Drug Policy. 2011-4-8

[9]
Synthetic cannabis.

Tidsskr Nor Laegeforen. 2012-10-30

[10]
Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.

J Forensic Leg Med. 2013-8

引用本文的文献

[1]
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy.

Brain Behav. 2025-4

[2]
Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo-Pyridyl Synthetic Cannabinoid Receptor Agonist CH-FUBBMPDORA.

Drug Test Anal. 2025-9

[3]
Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models.

Forensic Toxicol. 2025-1

[4]
Rapid screening and identification of novel psychoactive substances using PaperSpray interfaced to high resolution mass spectrometry.

Clin Mass Spectrom. 2016-9-28

[5]
Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers.

Naunyn Schmiedebergs Arch Pharmacol. 2025-2

[6]
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.

Harm Reduct J. 2024-7-1

[7]
Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective.

Saudi Pharm J. 2024-4

[8]
Alternative Crops for the European Tobacco Industry: A Systematic Review.

Plants (Basel). 2024-1-15

[9]
Abuse of Synthetic Cannabinoids and Cathinones in a Patient on Buprenorphine-Naloxone Treatment: A Case Report.

Cureus. 2023-11-6

[10]
Shifting drug markets in North America - a global crisis in the making?

Int J Ment Health Syst. 2023-10-25

本文引用的文献

[1]
Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.

Fed Regist. 2013-5-16

[2]
A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors.

Chem Res Toxicol. 2012-3-15

[3]
Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.

J Mass Spectrom. 2012-1

[4]
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Biochem Pharmacol. 2012-1-18

[5]
Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.

Handb Exp Pharmacol. 2012

[6]
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.

Prog Neuropsychopharmacol Biol Psychiatry. 2011-12-30

[7]
Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.

Methods Mol Biol. 2012

[8]
Convulsions associated with the use of a synthetic cannabinoid product.

J Med Toxicol. 2012-3

[9]
1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice.

Drug Alcohol Depend. 2011-11-27

[10]
Designer drugs: a medicinal chemistry perspective.

Ann N Y Acad Sci. 2011-11-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索